Clinical Trial Update: Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of F-627 in women with breast cancer receiving myelotoxic chemotherapy has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neutropenia

Drugs mentioned

• F-627

Snippet

Sponsor: EVIVE Biotechnology | Conditions: Breast Cancer, Neutropenia | Phase 2 | Status: COMPLETED | Results posted: 2018-03-20